Kaj Blennow Selected Research

Neurocan

5/2021	Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus.
1/2021	Cerebrospinal fluid brevican and neurocan fragment patterns in human traumatic brain injury.
1/2021	Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
9/2019	Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaj Blennow Research Topics

Disease

910	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 03/2000
286	Dementia (Dementias) 05/2024 - 03/2000
274	Cognitive Dysfunction 05/2024 - 01/2003
112	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2024 - 01/2002
66	Atrophy 05/2024 - 01/2007
60	Neuroinflammatory Diseases 05/2024 - 12/2009
54	Inflammation (Inflammations) 04/2024 - 09/2004
53	Parkinson Disease (Parkinson's Disease) 01/2024 - 04/2004
51	Amyloid Plaque 11/2023 - 07/2002
48	Disease Progression 05/2024 - 07/2002
48	Brain Injuries (Brain Injury) 01/2024 - 02/2003
36	Frontotemporal Dementia (Semantic Dementia) 11/2023 - 01/2002
34	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2024 - 01/2004
32	Amyloidosis 05/2024 - 07/2013
31	Multiple Sclerosis 04/2024 - 03/2007
29	Stroke (Strokes) 04/2024 - 01/2006
23	COVID-19 01/2024 - 01/2020
19	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2023 - 03/2002
17	Bipolar Disorder (Manic Depressive Psychosis) 05/2024 - 12/2009
17	Gliosis 01/2024 - 01/2018
16	Ischemic Stroke 04/2024 - 01/2014
15	Nervous System Diseases (Neurological Disorders) 01/2024 - 10/2008
15	Parkinsonian Disorders (Parkinsonism) 12/2023 - 02/2003
15	Normal Pressure Hydrocephalus 10/2023 - 04/2013
14	Heart Arrest (Cardiac Arrest) 01/2024 - 01/2011
14	Delirium 01/2023 - 01/2017
13	Brain Concussion (Cerebral Concussion) 04/2024 - 04/2013
13	Tauopathies 01/2023 - 11/2012
13	Schizophrenia (Dementia Praecox) 11/2022 - 01/2002
13	Neurobehavioral Manifestations 06/2022 - 12/2011
12	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 05/2024 - 11/2012
12	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 10/2023 - 11/2012
12	Down Syndrome (Down's Syndrome) 04/2023 - 01/2007
11	Wounds and Injuries (Trauma) 04/2024 - 02/2003
10	Infections 05/2024 - 06/2010
10	Brain Diseases (Brain Disorder) 05/2024 - 07/2013
10	Craniocerebral Trauma (Head Injury) 02/2024 - 08/2009
10	Genetic Risk Score 02/2023 - 01/2017
9	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2024 - 01/2002
9	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2024 - 07/2010
9	Neoplasms (Cancer) 11/2023 - 04/2013
8	Chronic Traumatic Encephalopathy 02/2024 - 05/2015
8	Relapsing-Remitting Multiple Sclerosis 09/2023 - 04/2015
8	Pathologic Processes 07/2023 - 10/2009
8	Emergence Delirium 01/2023 - 01/2019
8	Alcoholism (Alcohol Abuse) 01/2012 - 11/2002
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2024 - 01/2004
7	Mental Disorders (Mental Disorder) 03/2024 - 02/2016
7	Hypertension (High Blood Pressure) 01/2023 - 01/2005
7	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 11/2022 - 04/2004
7	Encephalitis (Encephalitis, Rasmussen) 11/2022 - 11/2017
7	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 04/2010
6	Obesity 04/2024 - 11/2004

Drug/Important Bio-Agent (IBA)

899	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2000
407	Amyloid (Amyloid Fibrils)IBA 05/2024 - 01/2003
228	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2002
135	Amyloid beta-PeptidesIBA 04/2024 - 01/2002
96	Apolipoproteins E (ApoE)IBA 05/2024 - 04/2003
85	Peptides (Polypeptides)IBA 04/2024 - 01/2005
72	NeurograninIBA 02/2024 - 11/2010
71	Glial Fibrillary Acidic ProteinIBA 04/2024 - 05/2007
48	ApolipoproteinsIBA 10/2023 - 11/2004
41	tau Proteins (tau Protein)IBA 01/2024 - 08/2002
25	Amino Acids FDA Link 12/2023 - 08/2002
23	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 04/2024 - 01/2016
22	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2023 - 09/2003
21	EnzymesIBA 01/2022 - 09/2003
20	SynucleinsIBA 01/2024 - 01/2014
19	Protein Isoforms (Isoforms)IBA 01/2023 - 05/2002
19	Threonine (L-Threonine)FDA Link 01/2023 - 08/2002
16	LipidsIBA 03/2024 - 01/2005
16	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 11/2004
15	CytokinesIBA 10/2023 - 03/2002
13	Phosphopyruvate Hydratase (Enolase)IBA 01/2024 - 02/2003
12	Serum AlbuminIBA 01/2023 - 04/2010
11	Interleukin-6 (Interleukin 6)IBA 03/2024 - 08/2003
11	CholesterolIBA 01/2024 - 01/2003
11	Interleukin-8 (Interleukin 8)IBA 10/2023 - 10/2014
10	Apolipoprotein E4IBA 05/2024 - 07/2012
10	Fatty Acid Binding Protein 3IBA 10/2023 - 01/2010
9	AntibodiesIBA 03/2024 - 07/2012
9	GAP-43 Protein (GAP 43 Protein)IBA 01/2024 - 12/2016
9	Monoclonal AntibodiesIBA 11/2023 - 04/2010
9	Cholinergic Agents (Cholinergics)IBA 11/2023 - 01/2013
8	Chitinase-3-Like Protein 1IBA 10/2023 - 01/2016
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 03/2002
8	Flavin-Adenine Dinucleotide (FAD)IBA 01/2023 - 01/2017
8	Complement System Proteins (Complement)IBA 01/2022 - 05/2007
8	ImmunosorbentsIBA 07/2021 - 09/2003
7	Indicators and Reagents (Reagents)IBA 05/2024 - 11/2013
7	ProteomeIBA 05/2024 - 04/2002
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 08/2003
7	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2023 - 04/2010
7	Blood Proteins (Serum Proteins)IBA 01/2023 - 01/2019
6	C-Reactive ProteinIBA 04/2024 - 01/2020
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2023 - 01/2015
6	flutemetamolIBA 11/2023 - 10/2014
6	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2023 - 01/2016

Therapy/Procedure

57	Therapeutics 04/2024 - 11/2007
7	Immunotherapy 12/2023 - 04/2008